Findings demonstrate improved radiolytic stability of chelators in nuclear medicine, suggesting enhanced use of radionuclides.
The growing use of radionuclides in nuclear medicine for therapy and diagnosis requires the development of chelators that combine high complexation performance with strong radiolytic stability. Macropa, an ether-crown ligand,...
No takes yet. Share an insight, caveat, or question.
Gaspar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: